<code id='092A17EB9F'></code><style id='092A17EB9F'></style>
    • <acronym id='092A17EB9F'></acronym>
      <center id='092A17EB9F'><center id='092A17EB9F'><tfoot id='092A17EB9F'></tfoot></center><abbr id='092A17EB9F'><dir id='092A17EB9F'><tfoot id='092A17EB9F'></tfoot><noframes id='092A17EB9F'>

    • <optgroup id='092A17EB9F'><strike id='092A17EB9F'><sup id='092A17EB9F'></sup></strike><code id='092A17EB9F'></code></optgroup>
        1. <b id='092A17EB9F'><label id='092A17EB9F'><select id='092A17EB9F'><dt id='092A17EB9F'><span id='092A17EB9F'></span></dt></select></label></b><u id='092A17EB9F'></u>
          <i id='092A17EB9F'><strike id='092A17EB9F'><tt id='092A17EB9F'><pre id='092A17EB9F'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:71
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more
          After Sarepta trial failure, Duchenne families brace for more debate
          After Sarepta trial failure, Duchenne families brace for more debate

          KristofferTripplaar/SipaviaAPTohearSareptaCEODougIngramtellit,theresultsMondayafternoonfromalargetri

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Brain injuries and the importance of a second opinion

          Photoillustration:CaseySheneryforSTATHowoldisClaireSnyman?“Iamnow…”shesayswithpause.“Ialwayshavetoth